In its experiment, a team of 12 from Dhaka University and Dhaka Medical College administered a small dose (25 mg) of eltrombopag to 101 dengue patients and saw the success of the drug, a release issued by Dhaka University's Department of Biochemistry and Molecular Biology said. Dr Sajib Chakraborty, associate professor of the department, who is also one of the researchers, said: “One of the symptoms of dengue is low blood platelets. But there is a medicine called eltrombopag that increases blood platelets. Also Read- Dengue threat looms largeDr Chakraborty said, “Since the number of platelets in dengue patients decreases, we have speculated that this medicine may work to increase the platelet count in patients. Then we started experimenting with this.”“We have seen good results in our research,” he said, adding: “About 92% of the dengue patients — who took eltrombopag — had their platelet counts returned to normal in eight days.

Source: Dhaka Tribune November 25, 2020 14:37 UTC